CHROMAgar™ LIN-R as an efficient screening tool to assess the prevalence of linezolid-resistant enterococci in German hospital patients-a multicentre study approach, 2021-2022.

Jennifer K BenderElsa BaufeldKarsten BeckerHeike ClausAnna DudakovaAchim DörreNikoletta FilaCarola FleigeAxel HamprechtArmin HoffmannMichael HogardtAchim J KaaschAxel KolaNancy KriebelFranziska Layer-NicolaouMatthias MarschalErnst Molitor Nico Tom MuttersJan LieseClaudia NelkenbrecherBernd Neumann Holger RohdeJörg SteinmannMichael SörensenPhilipp ThelenMichael WeigAndreas E ZautnerGuido Werner

Published in: The Journal of antimicrobial chemotherapy (2023)

CHROMAgar™ LIN-R represents a simple and efficient LRE screening tool in hospital settings. A high proportion of false-positive results demands validation of linezolid resistance by a reference method.

Keyphrases

methicillin resistant staphylococcus aureus
end stage renal disease
healthcare
ejection fraction
newly diagnosed
acute care
adverse drug
emergency department
patient reported